SVLSF Iv, LLC, 10% Owner at KalVista Pharmaceuticals, Inc. (KALV), sold 32,983 shares at $20.00 ($660K) on 2018-12-31, disclosed to the SEC on 2019-01-02.
Open-market sale of $660k KALV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.03 | 103 | $2K | 0.3% |
| 2 | $20.03 | 3,631 | $73K | 11.0% |
| 3 | $20.03 | 3,631 | $73K | 11.0% |
| 4 | $20.00 | 702 | $14K | 2.1% |
| 5 | $20.00 | 24,716 | $494K | 74.9% |
| 6 | $20.00 | 6 |
| $120 |
| 0.0% |
| 7 | $20.00 | 194 | $4K | 0.6% |
| Total | $20.01 avg | 32,983 | $660K | 100% |
| Filing → |
| ENTL | BUY | 2015-02-04 | $5.4M | — | Filing → |
| OCUL | BUY | 2014-07-31 | $6.2M | — | Filing → |
| OPHT | SELL | 2014-06-02 | $25.5M | — | Filing → |